Inactive Instrument

CEREP Stock Euronext Paris

Equities

FR0004042232

Biotechnology & Medical Research

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

2023	Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2022	Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022	CI

Financials

Sales 2021	41.63M 44.52M	Sales 2022	47.65M 50.95M	Capitalization	112M 120M
Net income 2021	9M 9.62M	Net income 2022	11M 11.76M	EV / Sales 2021	2.05 x
Net cash position 2021	1.28M 1.37M	Net cash position 2022	12.81M 13.7M	EV / Sales 2022	2.08 x
P/E ratio 2021 *	-	P/E ratio 2022	-	Employees	-
Yield 2021 *	-	Yield 2022	-	Free-Float	4.22%

More Fundamentals * Assessed data

Latest news about CEREP

Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-29	CI
Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-29	CI
Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-11	CI
Global markets live: Daimler, GSK, Mattel	21-04-16
Eurofins Cerep : Launches PCR COVID-19 Self-Test In Germany, Spain	20-12-23	MT
Eurofins-Cerep Sa Reports Earnings Results for the Half Year Ended June 30, 2020	20-09-24	CI
Eurofins Cerep SA acquired KVI-Plusz.	18-07-29	CI
Eurofins Cerep SA and Jean-Louis Oger, along with the members of the current leadership of Bioaccess, completed the acquisition of a majority stake in Bioaccess S.A.	15-08-03	CI
Eurofins Cerep SA and Jean-Louis Oger, along with the members of the current leadership of Bioaccess, agreed to acquire majority stake in Bioaccess S.A. for €225 million.	15-06-17	CI
Eurofins-Panlabs, Inc. completed the acquisition of Cerep Inc. from Cerep SA.	13-12-30	CI
Eurofins-Panlabs, Inc. agreed to acquire Cerep Inc. from Cerep SA for $0.27 million.	13-12-12	CI
Eurofins Discovery Services Lux Holding completed the acquisition of 8.48% stake in Cerep SA from Thierry Jean.	13-03-31	CI
Eurofins Scientific SA completed the acquisition of 75.13% stake in Cerep SA for €18.9 million.	13-02-27	CI
Eurofins Scientific SA made an offer to acquire remaining 91.52% stake in Cerep SA for €23.1 million.	12-12-20	CI
Eurofins Discovery Services Lux Holding agreed to acquire 8.48% stake in Cerep SA from Thierry Jean for €2.1 million.	12-12-20	CI

More news

Press releases CEREP

Eurofins Cerep : annonce ses résultats 2022

23-04-12

More press releases

News in other languages on CEREP

Le bric-à-brac de Zonebourse : Tuto pour le FedWatch, actions ultra-chères et Carmat	Jan. 18
Plus c'est long, moins c'est bon	23-09-21
En Direct des Marchés : Carrefour, Engie, Unibail, Casino, Valneva, Delivery Hero, Fedex, Bayer...	23-09-21
Lo sapevi? Société des Chemins de Fer et Tramways du Var et du Gard	23-08-24
Le saviez-vous ? Société des Chemins de Fer et Tramways du Var et du Gard	23-08-22

More news

Managers and Directors - CEREP

Managers	Title	Age	Since
Antoine Duthilleul CEO	Chief Executive Officer	-	18-04-18
Damien Séroux CHM	Chairman	-	14-10-12

Members of the board	Title	Age	Since
Damien Séroux CHM	Chairman	-	14-10-12
Christina Shasserre BRD	Director/Board Member	68	15-06-09
Antoine Duthilleul CEO	Chief Executive Officer	-	18-04-18

More insiders

Company Profile

Eurofins Cerep (formerly Eurofins-Cerep) specializes in the pre-clinical research of drugs for the pharmaceutical industry. Exports account for 97.9% of net sales.

Sector

Biotechnology & Medical Research

Calendar

2024-05-22 - Shareholders Meeting

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+1.51%	42.59B
MODERNA, INC.	+8.57%	40.65B
LONZA GROUP AG	+49.22%	40.57B
CELLTRION, INC.	-12.36%	26.77B
ICON PUBLIC LIMITED COMPANY	+8.92%	24.81B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.17B
MEDPACE HOLDINGS, INC.	+29.17%	12.05B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.7B
UNITED THERAPEUTICS CORPORATION	+6.35%	11.1B